A paper published today in Nature isolates the specific nucleotides responsible for driving a biologist to commodify the building blocks of life. The breakthrough provides a complete map of the late geneticist's unparalleled audacity.
Utilizing the rapid shotgun sequencing techniques Venter himself pioneered at Celera Genomics, lead author Dr. Francis Collins reports in Nature that his team successfully mapped the late scientist's biological imperative to privatize the human genome. By examining tissue from Venter, who died at 79, researchers identified a densely packed gene cluster on chromosome 14 that dictates aggressive venture-capital fundraising and an innate physiological aversion to open-source data sharing. The sheer elegance of this localized mutation, functioning as a flawless biochemical engine generating the urge to copyright naturally occurring proteins, is nothing short of breathtaking.
Following the publication, independent geneticists praised the methodological rigor of the federal research team but urged caution regarding the broader evolutionary implications of the discovery.
While the isolation of this monetization allele is undeniably fascinating, it is entirely too early to tell whether the trait is heritable or simply a spontaneous mutation caused by prolonged exposure to biotech investors.